The Administrative Core is critical to the success of the SPORE. The specific objectives of the Administrative Core are: ? Provide oversight of all activities of the SPORE, including Projects and Core support ? Ensure compliance with all general, governmental, and NCI regulations and requirements ? Assume responsibility for communication and consultation with the NCI project officer and other NCI staff in preparation of all required reports and publications ? Oversee coordination of data control quality assurance issues in conjunction with the Internal Scientific Advisory Board and the Biostatistics Core ? Provide oversight and support for the Biostatistics and Data Management Core (Core B) and the Tissue Procurement and Pathology Core (Core C) ? Assume responsibility for maintenance of fiscal and budgetary functions ? Convene all necessary meetings including the Executive Committee, the Internal and External Advisory Committees, monthly investigators'meetings, quarterly research meetings, lectures, and symposia ? Oversee administration of the Developmental Research Program ? Oversee administration of the Career Development Program ? Establish and monitor policies for recruitment of women and minorities ? Coordination with other Breast SPORE programs and investigators, as well as those of other organ site SPORE programs, to promote and maintain communication and integration through sponsoring a yearly conference, and also through the distribution of materials, electronic communications and evaluation of progress reports. The Administrative Core will be led by Drs. Gabriel N. Hortobagyi and Mien-Chie Hung, both of whom have extensive expertise in the successful and productive management of large, rnultidisciplinary research programs. The Core leaders participate in multiple NCI-sponsored activities, maintain good working relationships with members of the National Cancer Institute and National Institutes of Health and are very familiar and in full compliance with all policies and procedures required of NCI- and NIH-funded research programs.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA116199-05
Application #
7906044
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
2012-08-31
Budget Start
2009-09-01
Budget End
2012-08-31
Support Year
5
Fiscal Year
2009
Total Cost
$133,378
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Nanos-Webb, A; Bui, T; Karakas, C et al. (2016) PKCiota promotes ovarian tumor progression through deregulation of cyclin E. Oncogene 35:2428-40
Jabbour-Leung, Natalie A; Chen, Xian; Bui, Tuyen et al. (2016) Sequential Combination Therapy of CDK Inhibition and Doxorubicin Is Synthetically Lethal in p53-Mutant Triple-Negative Breast Cancer. Mol Cancer Ther 15:593-607
Lucenay, Kimberly S; Doostan, Iman; Karakas, Cansu et al. (2016) Cyclin E Associates with the Lipogenic Enzyme ATP-Citrate Lyase to Enable Malignant Growth of Breast Cancer Cells. Cancer Res 76:2406-18
Gaur, Sanchaika; Wen, Yunfei; Song, Jian H et al. (2015) Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagy. Oncotarget 6:29161-77
Wen, Yunfei; Graybill, Whitney S; Previs, Rebecca A et al. (2015) Immunotherapy targeting folate receptor induces cell death associated with autophagy in ovarian cancer. Clin Cancer Res 21:448-59
Qi, Yuan; Liu, Xiuping; Liu, Chang-Gong et al. (2015) Reproducibility of Variant Calls in Replicate Next Generation Sequencing Experiments. PLoS One 10:e0119230
Guan, Xiaoxiang; Liu, Hongliang; Ju, Jingfang et al. (2015) Genetic variant rs16430 6bp > 0bp at the microRNA-binding site in TYMS and risk of sporadic breast cancer risk in non-Hispanic white women aged ? 55 years. Mol Carcinog 54:281-90
Gutierrez-Rubio, S A; Quintero-Ramos, A; Durán-Cárdenas, A et al. (2015) 1236 C/T and 3435 C/T polymorphisms of the ABCB1 gene in Mexican breast cancer patients. Genet Mol Res 14:1250-9
Nodora, Jesse N; Cooper, Renee; Talavera, Gregory A et al. (2015) Acculturation, Behavioral Factors, and Family History of Breast Cancer among Mexican and Mexican-American Women. Womens Health Issues 25:494-500
Wen, Yunfei; Zand, Behrouz; Ozpolat, Bulent et al. (2014) Antagonism of tumoral prolactin receptor promotes autophagy-related cell death. Cell Rep 7:488-500

Showing the most recent 10 out of 137 publications